Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria (Q38302430)

1 September 2017

Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria (English)

1 reference

polycystic ovary syndrome

1 September 2017

1 reference

1 reference

1 reference

7

Ammarin Thakkinstian

1 reference

1 September 2017

Sawaek Weerakiet

1

1 reference

1 September 2017

Pongamon Bunnag

2

1 reference

1 September 2017

Bunyong Phakdeekitcharoen

3

1 reference

1 September 2017

Surapee Wansumrith

4

1 reference

1 September 2017

Suwannee Chanprasertyothin

5

1 reference

1 September 2017

Rattiya Jultanmas

6

1 reference

1 September 2017

1 March 2007

1 reference

Gynecological Endocrinology

1 September 2017

1 reference

1 September 2017

23

1 reference

1 September 2017

3

1 reference

1 September 2017

153-160

1 reference

The dysmetabolic syndrome

1 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Diagnosis of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Polycystic ovary syndrome: clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Insulin action in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Prospective analysis of the insulin-resistance syndrome (syndrome X).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Impaired coronary collateral vessel development in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Is a single definition of the metabolic syndrome appropriate?--A comparative study of the USA and Asia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Prevalence of the metabolic syndrome among Italian adults according to ATP III definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Serum adiponectin levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214158

10.1080/09513590701214158

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference